Williams Donald Allen purchased $29K of PALI
Williams Donald Allen purchased 20,000 shares of PALISADE BIO, INC. (PALI) at an average of $1.44 ($1.42–$1.46) across 2 trades over 2026-10-01 to 2026-10-02.
How this was made
The 30-second read
Why it matters
The disclosed purchase is modest and unlikely to move the stock significantly, but it adds a data point for monitoring insider activity.
Market read
Small insider buy adds a minor positive signal but has limited trading relevance.
What to watch
The director's overall ownership is already sizable; incremental purchase may not change control dynamics.
Background
Form 4 filings disclose insider trades; investors watch them for signals of confidence.
Ticker impact
Director Williams Donald Allen bought 20,000 shares for $28,800, raising his stake to 1,590,294 shares.
potential modest upside as market prices in insider buying
The transaction is a primary Form 4 filing, but the dollar amount is low, limiting material impact.
Market effects
Minimal effect on biotech sector; insider buying is too small to shift sentiment.
None
None
Counterpoint
The purchase may be routine portfolio rebalancing rather than a strong endorsement.
Key entities
- DirectorWilliams Donald Allen
Director of Palisade Bio who executed the purchase.
- CompanyPalisade Bio, Inc.
Biotech firm listed on Nasdaq under ticker PALI.
